Acorn Bioventures
New York City, New Yorkacornbioventures.com
Overview
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to provide value across the entire specturm forom seeed financing, cross-over financings, IPOs, registered direct offerings, PIPEs, open market purchases, etc. Management teams of our portfolio companies are our long-term partners and we are proud to be part of the entreprenurial spirit and pionerring spirit in biotech.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cybin | Mar 2026 | Private Placement | Co-investor |
| Neuron23 | Jun 2025 | Series D | Co-investor |
| OnKure Therapeutics | Oct 2024 | Private Placement | Co-investor |
| Acrivon Therapeutics | Apr 2024 | PIPE | Co-investor |
| Neurosterix | Apr 2024 | Series A | Co-investor |
Key People
Anders Hove
Partner and Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.